Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Calcium Levels Linked to Ovarian Cancer

By LabMedica International staff writers
Posted on 13 Feb 2013
High blood calcium levels might predict ovarian cancer, the most fatal of the gynecological cancers. More...


Many ovarian cancers express parathyroid hormone-related protein, which acts to raise calcium levels in serum, which may be a biomarker for ovarian cancer.

Cancer epidemiologists at Wake Forest Baptist Medical Center (Winston-Salem, NC, USA) measured total and ionized serum calcium levels using ion-specific electrodes. They were pH-adjusted because the protein binding of calcium is affected by pH; ionized calcium in blood is commonly corrected to standard pH. Serum samples were collected as part of Third National Health and Nutrition Examination Surveys (NHANES III) between 1988 and 1994 from two nationally representative prospective cohorts.

Eleven ovarian cancer deaths were observed over 95,556 person-years of follow-up through December 31, 2006, representing 137,404 ovarian cancer deaths in the United States of America. The range in total serum calcium in cases was 2.14–2.44 mmol/L and for ionized serum calcium was 1.17–1.31 mmol/L. The normal reference range for total serum calcium is approximately 2.17–2.52 mmol/L and 1.12–1.32 mmol/L for ionized serum calcium. In the second cohort, there were eight ovarian cancer cases in over 31,089 person-years of follow-up. The range of total serum calcium was 1.98–2.93 mmol/L. The relative hazard for fatal ovarian cancer was 1.52 per 0.1 mmol/L increase in total serum calcium and 2.44 per 0.1 mmol/L increase in ionized serum calcium.

Gary G. Schwartz, PhD, the lead author of the study, said "One approach to cancer biomarker discovery is to identify a factor that is differentially expressed in individuals with and without cancer and to examine that factor's ability to detect cancer in an independent sample of individuals." His coauthor added, "Everyone's got calcium and the body regulates it very tightly. We know that some rare forms of ovarian cancer are associated with very high calcium, so it's worth considering whether more common ovarian cancers are associated with moderately high calcium."

The authors concluded that this biomarker, the higher levels of calcium in serum, were significantly positively associated with the risk of ovarian cancer in two prospective cohorts. The principal limitation of this study is the small number of cases. Conversely, the study has several strengths: it is prospective, uses population-based data from two nationally representative cohorts, and is the first to study ionized serum calcium. The existence of stored sera from sample sets of women with and without ovarian cancer should facilitate the confirmation or refutation of the association between serum calcium and ovarian cancer. The study was published January 9, 2013, in the journal Gynecologic Oncology.

Related Links:
Wake Forest Baptist Medical Center



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.